本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Forte BioSciences Inc

15.49
+2.0515.25%
盘后15.600.1100+0.71%19:58 EDT
成交量:6.52万
成交额:93.80万
市值:1.93亿
市盈率:-1.88
高:15.49
开:13.41
低:13.41
收:13.44
52周最高:28.68
52周最低:4.11
股本:1,243.29万
流通股本:926.19万
量比:0.61
换手率:0.70%
股息:- -
股息率:- -
每股收益(TTM):-8.2404
每股收益(LYR):-12.1671
净资产收益率:-73.46%
总资产收益率:-40.79%
市净率:1.95
市盈率(LYR):-1.27

数据加载中...

2024/01/11

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/09

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/05

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/08

重要事件披露

Form 8-K - Current report
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/27

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/09/21

重要事件披露

Form 8-K - Current report
2023/09/21

重要事件披露

Form 8-K - Current report
2023/09/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/09

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/06

SEC问询函

Form CORRESP - Correspondence
2023/08/30

SEC问询函

Form CORRESP - Correspondence
2023/08/24

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/08/15

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/11

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/11

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/10

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/04

重要事件披露

Form 8-K - Current report